CoreAge Rx and AgelessRx both advertise online clinical evaluation for compounded NAD+. The useful differences are the selected route, how a plan is billed, and what the provider’s research claims actually establish.
CoreAge is NAD Atlas’s featured commercial partner. This comparison uses public information checked September 19, 2026; it does not rank clinical outcomes or claim firsthand treatment experience with either service.
Compare the selected plan and route first. AgelessRx’s quarterly introductory offer and research program need context; CoreAge’s featured placement is commercial, not a clinical verdict.
The injection price needs the plan beside it
CoreAge’s offer and product pages show different starting prices; confirm which applies to the selected plan. AgelessRx’s current injection page advertises $79 for the first month on a three-month plan billed in full, with $149/month afterward. That is not simply a $79 month-to-month offer.
Request the initial total, renewal amount, billing interval, and supply period from both providers. The CoreAge review explains its two public price points, while the AgelessRx review distinguishes product-page terms from separate promotions.
A nasal comparison is a separate purchase
Both brands have nasal NAD pages, but injection prices should not be carried across to them. AgelessRx publicly distinguishes monthly and one-time nasal purchase options. That creates a different commitment question from its quarterly injection promotion.
If avoiding needles is the main priority, compare the actual nasal prescriptions and support arrangements. Use the nasal versus injection guide before assuming that the routes deliver equivalent exposure or benefits.
AgelessRx’s research visibility is worth examining closely
A provider can describe a research team, a competition, a customer survey, and published studies on the same page. Those are different kinds of evidence. Ask which investigation tested the exact product and route you are considering and whether other interventions were used at the same time.
The presence of a research program does not establish that every marketed NAD route improves cognition, energy, or longevity. Equally, commercial placement on this site does not supply that evidence for CoreAge.
Compare the actual clinical relationship
Ask whether questions reach the prescribing team, whether live appointments are available when needed, and how a change in symptoms affects refills. A stated messaging benefit is useful information, but it does not measure response quality or establish that the service suits your concern.
Confirm the clinician’s authority for your location and the dispensing pharmacy’s identity. Neither national branding nor an accepted intake form answers every eligibility question.
What would settle the choice
A reader focused on billing flexibility should first compare the chosen term and cancellation rules. A reader focused on research should ask for the exact supporting paper and its clinical endpoint. A reader focused on nasal care should request a route-specific quote from each.
Compounded prescriptions are not FDA-approved. Pharmacy controls, labeling, and follow-up remain relevant for both services, regardless of which public offer looks simpler.
Sources & reading notes
Editorial source review updated September 19, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- CoreAge Rx: current NAD+ offer Provider advertising; offer page displays $99/month. Checked September 19, 2026.
- CoreAge Rx: NAD+ Injectable product page Provider advertising; product page displays a different starting price of $93/month.
- AgelessRx: NAD+ Injection Provider product page. Customer surveys are not controlled clinical trials.
- AgelessRx: NAD+ Nasal Spray Provider lists $125/month subscription and $140 one-time purchase; customer check-ins are uncontrolled reports. Checked September 18, 2026.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.